A Randomised Double-blind Study to Compare the Analgesic Efficacy and Safety Profiles of M6G and Morphine, as a Loading Dose Followed by PCA, in Patients Suffering Moderate to Severe Post-operative Pain Requiring PCA for at Least 24 Hours.

Trial Profile

A Randomised Double-blind Study to Compare the Analgesic Efficacy and Safety Profiles of M6G and Morphine, as a Loading Dose Followed by PCA, in Patients Suffering Moderate to Severe Post-operative Pain Requiring PCA for at Least 24 Hours.

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Jun 2011

At a glance

  • Drugs Morphine; Morphine-6-glucuronide
  • Indications Postoperative pain
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 01 Apr 2011 Results published in the European Journal of Pain.
    • 10 Mar 2010 Actual end date (Dec 2006) added as reported by ClinicalTrials.gov.
    • 10 Mar 2010 Official title, start date (Nov 2005), lead trial investigators (Binning A, Lees J) and additional locations (Czech Republic, France, Scotland, Germany, Netherlands, Poland) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top